Three doses of COVID-19 mRNA vaccination induce long-lasting antibody and memory B-cell responses, according to a study of ...

We recently published a list of 10 Best Long Term Growth Stocks to Buy According to Billionaires. In this article, we are ...

Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.

“Cleveland Clinic: Millions of COVID-vaxxed will die within ‘5 years,’” the headline said. This Facebook post was flagged as ...

Alarming Findings Surface as COVID Vaccine Fallout Unfolds** A startling investigation reveals that embalmers have been encountering unusual fibrous clots in a significant perce ...

From stock decline to Hold rating, explore their growth strategy, client focus, and potential gains. Click for my MRVI update ...

As the respiratory syncytial virus (RSV) vaccine field grapples with a significantly reduced market size thanks to regulatory ...

Key Takeaways The U.S. Food and Drug Administration has delayed full approval of Novavax's COVID vaccineThe agency says it needs more data before making a final decisionNovavax says its vaccine is ...

In a series of interviews, experts highlight lasting health care innovations that emerged during the COVID-19 pandemic, including telemedicine, artificial intelligence (AI), and home-based treatment.

More top vaccine regulators at the FDA have either left or been forced out, which could hobble the agency's ability to ...

More top vaccine regulators at the FDA have either left or been forced out, which could hobble the agency's ability to approve new vaccines and drugs.